| Family history a strong risk factor for breast/ovarian cancer for BRCA1/2 mutation carriers Related items from OnMedica Experts recommend anastrozole for postmenopausal women with family history of breast cancer NICE set to approve trastuzumab emtansine for breast cancer Genetic research finds 15 new breast cancer ‘hotspots’ Radiotherapy during breast cancer surgery cuts cost and time |
Wednesday, 21 June 2017
Research reveals age-specific cancer risk with BRCA1/2
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment